Dose of nebulized ipratropium bromide in acute severe asthma (Q43860017)

27 November 2017

title

Dose of nebulized ipratropium bromide in acute severe asthma (English)

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(06)80270-2

6 December 2022

1 reference

K. F. Whyte

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1837931

6 December 2022

G. A. Gould

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1837931

6 December 2022

A. A. Jeffrey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1837931

6 December 2022

M. A. Airlie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1837931

6 December 2022

D. C. Flenley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1837931

6 December 2022

N. J. Douglas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1837931

6 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1837931

6 December 2022

publication date

1 November 1991

1 reference

full work available at URL

27 November 2017

https://api.elsevier.com/content/article/PII:S0954611106802702?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(06)80270-2

https://api.elsevier.com/content/article/PII:S0954611106802702?httpAccept=text/plain

6 December 2022

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(06)80270-2

6 December 2022

1 reference

27 November 2017

volume

85

1 reference

27 November 2017

issue

6

1 reference

27 November 2017

page(s)

517-520

1 reference

Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980270-2

7 January 2021

Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980270-2

7 January 2021

Ipratropium bromide in acute asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980270-2

7 January 2021

A place for ipratropium bromide in the treatment of severe acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980270-2

7 January 2021

Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980270-2

7 January 2021

Evaluation of Biox IIA ear oximeter

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980270-2

7 January 2021

Emergency use of nebulised bronchodilator drugs in British hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980270-2

7 January 2021

Nebulized ipratropium bromide in the treatment of acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980270-2

7 January 2021

Combined salbutamol and ipratropium bromide by inhalation in the treatment of severe acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980270-2

7 January 2021

Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980270-2

7 January 2021

Should ipratropium bromide be added to beta-agonists in treatment of acute severe asthma?

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980270-2

7 January 2021

Nebulized ipratropium in the treatment of acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980270-2

7 January 2021

Effect of an inhaled atropinelike agent on normal airway function

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980270-2

7 January 2021

Bronchodilatation and the site of airway resistance in severe chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980270-2

7 January 2021

Asthma: Comparative Bronchodilator Effects of Ipratropium Bromide and Isoproterenol

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980270-2

7 January 2021

Bronchodilator Action of the Anticholinergic Drug, Ipratropium Bromide (Sch 1000), as an Aerosol in Chronic Bronchitis and Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980270-2

7 January 2021

Is nocturnal asthma caused by changes in airway cholinergic activity?

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980270-2

7 January 2021

Comparison of ipratropium bromide and salbutamol by aerosolized solution

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980270-2

7 January 2021

Aerosol Sch 1000. An anticholinergic bronchodilator

18

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(06)80270-2

Sch 1000: a new anticholinergic bronchodilator

6 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(06)80270-2

6 December 2022

Identifiers

1 reference

27 November 2017

1 reference